181 related articles for article (PubMed ID: 29960963)
1. EBV colitis with ulcerative colitis: a double whammy.
Afzal M; Nigam GB
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29960963
[TBL] [Abstract][Full Text] [Related]
2. A Case of Ulcerative Colitis Following Acute Hepatitis Induced by Epstein-Barr Virus Infection.
Oh SH; You CR; Kim EO; Bae SH; Choi JY; Yoon SK; Choi SW
Korean J Gastroenterol; 2016 Aug; 68(2):104-8. PubMed ID: 27554218
[TBL] [Abstract][Full Text] [Related]
3. Is Epstein-Barr virus infection associated with the pathogenesis of microscopic colitis?
Rizzo AG; Orlando A; Gallo E; Bisanti A; Sferrazza S; Montalbano LM; Macaluso FS; Cottone M
J Clin Virol; 2017 Dec; 97():1-3. PubMed ID: 29078077
[TBL] [Abstract][Full Text] [Related]
4. Evidence of Epstein-Barr virus infection in ulcerative colitis.
Bertalot G; Villanacci V; Gramegna M; Orvieto E; Negrini R; Saleri A; Terraroli C; Ravelli P; Cestari R; Viale G
Dig Liver Dis; 2001 Oct; 33(7):551-8. PubMed ID: 11816543
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus (EBV) infection and expression of the interleukin-12 family member EBV-induced gene 3 (EBI3) in chronic inflammatory bowel disease.
Gehlert T; Devergne O; Niedobitek G
J Med Virol; 2004 Jul; 73(3):432-8. PubMed ID: 15170639
[TBL] [Abstract][Full Text] [Related]
6. Refractory inflammatory bowel disease: is there a role for Epstein-Barr virus? A case-controlled study using highly sensitive Epstein-Barr virus-encoded small RNA1 in situ hybridization.
Pezhouh MK; Miller JA; Sharma R; Borzik D; Eze O; Waters K; Westerhoff MA; Parian AM; Lazarev MG; Voltaggio L
Hum Pathol; 2018 Dec; 82():187-192. PubMed ID: 30120969
[TBL] [Abstract][Full Text] [Related]
7. Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: need for mucosal viral load measurement.
Ciccocioppo R; Racca F; Paolucci S; Campanini G; Pozzi L; Betti E; Riboni R; Vanoli A; Baldanti F; Corazza GR
World J Gastroenterol; 2015 Feb; 21(6):1915-26. PubMed ID: 25684960
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus in inflammatory bowel disease: the spectrum of intestinal lymphoproliferative disorders.
Nissen LH; Nagtegaal ID; de Jong DJ; Kievit W; Derikx LA; Groenen PJ; van Krieken JH; Hoentjen F
J Crohns Colitis; 2015 May; 9(5):398-403. PubMed ID: 25740811
[TBL] [Abstract][Full Text] [Related]
9. [Epstein-Barr virus-associated large B-cell lymphoma in a patient with colitis ulcerosa treated with azathioprine].
Kofoed K; Kiszka-Kanowitz M; Albrectsen JM; Andersen O
Ugeskr Laeger; 2008 Apr; 170(15):1255. PubMed ID: 18433585
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus associated T-cell lymphoproliferative disease misdiagnosed as ulcerative colitis: a case report.
Zheng X; Xie J; Zhou X
Int J Clin Exp Pathol; 2015; 8(7):8598-602. PubMed ID: 26339440
[TBL] [Abstract][Full Text] [Related]
11. Distribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease.
Spieker T; Herbst H
Am J Pathol; 2000 Jul; 157(1):51-7. PubMed ID: 10880375
[TBL] [Abstract][Full Text] [Related]
12. Impact of Epstein-Barr virus infection on inflammatory bowel disease (IBD) clinical outcomes.
Núñez Ortiz A; Rojas Feria M; de la Cruz Ramírez MD; Gómez Izquierdo L; Trigo Salado C; Herrera Justiniano JM; Leo Carnerero E
Rev Esp Enferm Dig; 2022 May; 114(5):259-265. PubMed ID: 34315215
[TBL] [Abstract][Full Text] [Related]
13. Substantial Epstein-Barr virus reactivation in a case of severe refractory ulcerative colitis: a possible role in exacerbation.
Kato S; Shimizu H; Tomii S; Uchida H; Kawamoto A; Hibiya S; Motobayashi M; Takenaka K; Fujii T; Saito E; Nagahori M; Ohtsuka K; Negi M; Akashi T; Matsuyama T; Kinugasa Y; Watanabe M
Clin J Gastroenterol; 2021 Apr; 14(2):584-588. PubMed ID: 33400186
[TBL] [Abstract][Full Text] [Related]
14. Impact of Epstein-Barr virus infection in patients with inflammatory bowel disease.
Zhang H; Zhao S; Cao Z
Front Immunol; 2022; 13():1001055. PubMed ID: 36389673
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-positive mucocutaneous ulcer arising in a post-hematopoietic cell transplant patient followed by polymorphic posttransplant lymphoproliferative disorder and cytomegalovirus colitis.
Satou A; Kohno A; Fukuyama R; Elsayed AA; Nakamura S
Hum Pathol; 2017 Jan; 59():147-151. PubMed ID: 27569297
[TBL] [Abstract][Full Text] [Related]
16. The hazardous burden of Herpesviridae in inflammatory bowel disease: the case of refractory severe ulcerative colitis.
Lavagna A; Bergallo M; Daperno M; Sostegni R; Ravarino N; Crocellà L; Ramella A; Rocca R; Torchio B; Cavallo R; Pera A
Dig Liver Dis; 2006 Dec; 38(12):887-93. PubMed ID: 16931197
[TBL] [Abstract][Full Text] [Related]
17. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).
Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P
Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus infection of the colon with inflammatory bowel disease.
Yanai H; Shimizu N; Nagasaki S; Mitani N; Okita K
Am J Gastroenterol; 1999 Jun; 94(6):1582-6. PubMed ID: 10364028
[TBL] [Abstract][Full Text] [Related]
19. Clinical Features of Intestinal Ulcers Complicated by Epstein-Barr Virus Infection: Importance of Active Infection.
Liu Y; Li Y; Li Y; Wu S; Tian X; Tang T; Sun H; He C
Dis Markers; 2021; 2021():6627620. PubMed ID: 34007344
[TBL] [Abstract][Full Text] [Related]
20. EBV-positive Bile Duct Carcinoma Associated with Ulcerative Colitis.
Ikeo K; Matsuda I; Hirota S
Intern Med; 2023 Nov; 62(22):3419-3420. PubMed ID: 37005265
[No Abstract] [Full Text] [Related]
[Next] [New Search]
